Cutler Group’s Ascendis Pharma A/S ASND Stock Holding History

Cutler Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$7K	Buy	+3,000	New	+$428K	﹤0.01%	1411
2022 Q4	–	Sell	-3,000	Closed	-$4K	–	4354
2022 Q3	$4K	Buy	+3,000	New	+$284K	﹤0.01%	3752
2022 Q2	–	Sell	-5,800	Closed	-$4K	–	4938
2022 Q1	$4K	Buy	+5,800	New	+$672K	﹤0.01%	4232
2021 Q4	–	Sell	-900	Closed	-$5K	–	5345
2021 Q3	$5K	Buy	+900	New	+$123K	﹤0.01%	4411
2021 Q2	–	Sell	-3,000	Closed	-$14K	–	5643
2021 Q1	$14K	Hold	3,000	–	–	﹤0.01%	3488
2020 Q4	$2K	Buy	+3,000	New	+$496K	﹤0.01%	4099
2020 Q3	–	Sell	-2,000	Closed	-$3K	–	4633
2020 Q2	$3K	Sell	2,000 -3,200	-62%	-$439K	﹤0.01%	3558
2020 Q1	$80K	Buy	+5,200	New	+$676K	﹤0.01%	1455
2019 Q3	–	Sell	-10,300	Closed	-$5K	–	4037
2019 Q2	$5K	Sell	10,300 -11,100	-52%	-$1.33M	﹤0.01%	3051
2019 Q1	$37K	Buy	21,400 +10,500	+96%	+$919K	﹤0.01%	1619
2018 Q4	$71K	Buy	10,900 +3,400	+45%	+$214K	0.01%	1263
2018 Q3	$40K	Buy	7,500 +5,000	+200%	+$344K	﹤0.01%	1744
2018 Q2	$12K	Buy	+2,500	New	+$164K	﹤0.01%	2521

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cutler Group's ASND Position: Q1 2024 in Review

Cutler Group opened a new position in Ascendis Pharma A/S (ASND) in Q1 2024: 440 shares worth $66K. The stake represents 0.02% of the portfolio and ranks #569 among its holdings. This is a return to the name: Cutler Group previously reported a position in ASND as recently as Q3 2023.

Cutler Group first reported a position in ASND in Q2 2018 and has held it in 12 quarters since. The position peaked at $1.13M in Q1 2022. 189 funds tracked by Wall St. Rank hold ASND as of Q1 2024.

Cutler Group held 440 shares of Ascendis Pharma A/S worth $66K as of Q1 2024.
Ascendis Pharma A/S was a new Cutler Group position in Q1 2024.
Ascendis Pharma A/S made up 0.02% of Cutler Group's portfolio in Q1 2024, its #569 holding.
Cutler Group first reported a position in Ascendis Pharma A/S in Q2 2018 and has held it in 12 quarters since.
Cutler Group's Ascendis Pharma A/S position peaked at $1.13M in Q1 2022.
189 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.